ReviewMicrobial biotechnology2025
On the Choice of the Right Plasmid Vector(s) in the Times of Synthetic Biology.
Review in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Environmental Release of Genetically Intervened Microorganisms: Towards a New Narrative.Microbial biotechnology · 2026Review
- On the Choice of the Right Plasmid Vector(s) in the Times of Synthetic Biology.Microbial biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Plasmid vectors are to this day the fundamental tools in molecular biology, but their selection is often guided by convenience rather than informed choice. This article revisits the architectural and functional features that determine plasmid performance i.e., origins of replication, copy number, cargo capacity, selection markers, and stability systems. We outline how these elements shape host range, expression dynamics, and metabolic burden, particularly as synthetic biology increasingly targets non-model bacteria. The growing need for reliable, portable vectors has driven the development of broad-host-range backbones, streamlined modular architectures such as SEVA, and alternatives to antibiotic-based selection. We also examine strategies to enhance long-term stability, including toxin-antitoxin systems and chromosomal integration via mini-transposons, recombinase-assisted platforms, and CRISPR-associated transposases. The convergence of standardization and customization, enabled by advances in DNA synthesis and emerging AI-assisted plasmid design tools is discussed also. These innovations promise flexible vector engineering tailored to diverse microbial chassis. Yet, a deeper, systems-level understanding of plasmid-host interactions will be necessary to ensure robust deployment of engineered functions in laboratory, industrial, and environmental settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.